Streamlining hit discovery and optimization with a yoctoliter scale DNA reactor

Author： Heitner Tara Renee Hansen Nils Jakob Vest

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.4, Iss.11, 2009-11, pp. : 1201-1213

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Discovery and Optimization of NAD+-Dependent DNA Ligase Inhibitors as Novel Antibacterial Compounds

Current Pharmaceutical Design, Vol. 23, Iss. 14, 2017-05 ,pp. : 2117-2130

Bentham Science Publishers

Access to resources Recommend Favorite

HIT

By Bennett A.

Journal of Substance Use, Vol. 6, Iss. 1, 2001-04 ,pp. : 49-50

Radcliffe Press

Access to resources Recommend Favorite

High-throughput screening and structure-based approaches to hit discovery: is there a clear winner?

By Jhoti Harren Rees Stephen Solari Roberto

Expert Opinion on Drug Discovery, Vol. 8, Iss. 12, 2013-12 ,pp. : 1449-1453

Informa Healthcare

Access to resources Recommend Favorite

NMR Screening and Hit Validation in Fragment Based Drug Discovery

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 1, 2011-01 ,pp. : 43-67

Bentham Science Publishers

Access to resources Recommend Favorite

Streamlining drug discovery: finding the right drug against the right target to treat the right disease

By Ng J.H. Ilag L.L.

Drug Discovery Today, Vol. 9, Iss. 2, 2004-01 ,pp. : 59-60

Elsevier

Access to resources Recommend Favorite